Riskpilot← Back to searchSign inGet full accessNOVO NORDISK PHARMACEUTICALS A/S
A/SActiveCVR 24257924Novo Alle 1Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 1974— employees
Revenue 2024
DKK -46K
0% vs 2023
EBITDA margin
100.0%
0% vs 2023
Equity ratio
38.9%
Financial strength
Net profit 2024
DKK 6,9M
+406% vs 2023
| Revenue | DKK -46K | +0% |
| EBITDA | DKK -46K | +0% |
| Net profit | DKK 6,9M | +406% |
| Total assets | DKK 26,3M | -76% |
| Equity | DKK 10,3M | -90% |
| Employees | — | — |
Legal name
NOVO NORDISK PHARMACEUTICALS A/S
CVR number
24257924
Legal form
Aktieselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
4. april 1974
Share capital
DKK 1.002.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 2 bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør.
Company purpose
Selskabtes formål er at drive fremstilling af og handel med lægemidler og dermed beslægtede produkter og anden dermed i forbindelse stående virksomhed, herunder forskning og investering.
Address
Novo Alle 1
Phone
+4544448888
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | 24.653 | 6.218 | -46 | -46 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -21 | -27 | -28 | -34 | -33 | -39 | 3.903 | 24.614 | 6.218 | -46 | -46 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -21 | -27 | -28 | -34 | -33 | -39 | 3.903 | 24.614 | 6.218 | -46 | -46 |
| Net financials | 3.171 | 1.884 | 1.713 | -2.259 | -1.958 | 3.760 | -6.186 | -23.580 | -12.375 | -1.143 | 7.354 |
| Profit before tax | 3.150 | 1.857 | 1.685 | -2.293 | -1.991 | 3.721 | -2.283 | 1.034 | -6.157 | -1.189 | 7.308 |
| Tax | -0 | -22 | -9 | -8 | -7 | -1 | 85 | -296 | -714 | 1.069 | 390 |
| Net profit | 3.150 | 1.879 | 1.694 | -2.285 | -1.984 | 3.722 | -2.368 | 1.330 | -5.443 | -2.258 | 6.918 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 12.579 | 14.442 | 16.138 | 13.859 | 11.880 | 15.602 | 2.958.624 | 3.048.757 | 210.245 | 111.169 | 26.328 |
| Equity | 12.543 | 14.422 | 16.116 | 13.831 | 11.847 | 15.569 | 2.849.704 | 2.851.034 | 105.591 | 103.333 | 10.251 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 88.914 | 174.818 | 0 | 0 | 0 |
| Short-term debt | 36 | 20 | 22 | 28 | 33 | 33 | 20.006 | 22.905 | 104.654 | 7.836 | 16.077 |
| Total debt | 36 | 20 | 22 | 28 | 33 | 33 | 108.920 | 197.723 | 104.654 | 7.836 | 16.077 |
EBITDA margin
-4600000.0%
This company
15.8%
Market median
-29114024% vs market
20142024
Equity ratio
38.9%
This company
38.2%
Market median
+2% vs market
20142024
Return on equity
67.5%
This company
18.4%
Market median
+267% vs market
20142024
Net profit margin
691800000.0%
This company
8.1%
Market median
+8540740641% vs market
20142024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20142024
Debt / equity
1.57×
This company
0.62×
Market median
-153% vs market
20142024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MØ Management | Management | 1974 | — | — |
LG Chief Executive Officer | Chief Executive Officer | 2005 | — | — |
PB Management | Management | 2018 | — | — |
R Audit | Audit | 1974 | — | — |
KA Management | Management | 1974 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1974 | — | — | |
| Chairman | 2000 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 1997 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2018 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2018 | — | — | |
| Chairman | 2005 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 1974 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NOVO NORDISK A/S | Company | 100.0% | 100.0% | 1974 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NOVO NORDISK FONDEN
NOVO NORDISK PHARMACEUTICALS A/S Board members of NOVO NORDISK PHARMACEUTICALS A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mads Øvlisen | Management | 0 companies |
| Lars Green | Chief Executive Officer | 0 companies |
| Peter Bøggild | Management | 0 companies |
| Revisam | Audit | 0 companies |
| Kurt Anker Nielsen | Management | 0 companies |
| Bent Hauerberg | Board of Directors | 0 companies |
| Lars Rebien Sørensen | Chairman | 0 companies |
| Lene Moth Bang | Board of Directors | 0 companies |
| Ole Falvig Ramsby | Board of Directors | 0 companies |
| Linette Tangsgaard Nielsen | Board of Directors | 0 companies |
| Kristine Aachmann Bethe | Board of Directors | 0 companies |
| Karsten Munk Knudsen | Chairman | 0 companies |
| Naja Eilers Barrisøe | Chairman | 0 companies |
| Tomas Haagen | Board of Directors | 0 companies |
| Jesper Brandgaard | Chairman | 0 companies |
| John Francis Kuckelman | Board of Directors | 0 companies |
| Kåre Schultz | Board of Directors | 0 companies |
| Lars Fruergaard Jørgensen | Board of Directors | 0 companies |
| Mads Ravn Sørensen | Board of Directors | 0 companies |